Steroid Pathway Genes and Neonatal Respiratory Distress after Betamethasone Use in Anticipated Preterm Birth

9Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Objective: To test several key glucocorticoid genes that are enhanced in lung development for associations with respiratory distress syndrome (RDS) after antenatal corticosteroid use. Methods: A prospective cohort of women received betamethasone to accelerate fetal lung maturity for threatened preterm delivery. DNA was obtained from mothers and newborns. Neonatal RDS was the primary outcome. Genotyping for single-nucleotide polymorphisms (SNPs) in 68 glucocorticoid genes found to be differentially expressed during lung development was performed. Multivariable analysis tested for associations of SNPs in the candidate genes with RDS. Results: Genotypic results for 867 SNPs in 96 mothers and 73 babies were included. Thirty-nine (53.4%) babies developed RDS. Maternal SNPs in the centromeric protein E (CENPE), GLRX, CD9, and AURKA genes provided evidence of association with RDS (P

Cite

CITATION STYLE

APA

Haas, D. M., Lai, D., Sharma, S., Then, J., Kho, A., Flockhart, D. A., … Foroud, T. (2016). Steroid Pathway Genes and Neonatal Respiratory Distress after Betamethasone Use in Anticipated Preterm Birth. Reproductive Sciences, 23(5), 680–686. https://doi.org/10.1177/1933719115612129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free